Abstract
Pyruvate carboxylase (PC) is an enzyme that catalyzes pyruvate carboxylation for the formation of a tricarboxylic acid (TCA) cycle intermediate, oxaloacetate. It plays a major role in the regulation of gluconeogenesis and replenishment of the TCA cycle for biosynthesis. In particular, fasting promotes gluconeogenesis from pyruvate, increasing PC flux. PC is under complex regulation by hormones, substates, and cofactors, in response to nutrient changes. Therefore, metabolic changes associated with PC need to be understood in the context of nutritional and physiological conditions. This chapter discusses currently available methods, from conventional approaches to state-of-the-art noninvasive in vivo imaging techniques, used in human and animal models to assess PC activity, particularly in fasting condition. Quantification of PC activity through in vitro or ex vivo isotopomer analysis and monitoring PC in vivo using hyperpolarized substrates are reviewed.
Similar content being viewed by others
Abbreviations
- Acetyl-CoA:
-
Acetyl coenzyme A
- ALT:
-
Alanine aminotransferase
- DNP:
-
Dynamic nuclear polarization
- HP:
-
Hyperpolarized
- IV:
-
Intravenous
- LDH:
-
Lactate dehydrogenase
- LPCKO:
-
Liver-specific knockout of Pcx gene
- MS:
-
Mass spectrometry
- NAFLD:
-
Nonalcoholic fatty liver disease
- NMR:
-
Nuclear magnetic resonance
- PC:
-
Pyruvate carboxylase
- PDH:
-
Pyruvate dehydrogenase
- PEP:
-
Phosphoenolpyruvate
- PEPCK:
-
Phosphoenolpyruvate carboxykinase
- T1:
-
Spin-lattice relaxation times
- TBI:
-
Traumatic brain injury
- TCA cycle:
-
Tricarboxylic acid cycle
References
Adina-Zada A, Zeczycki TN, St Maurice M, et al. Allosteric regulation of the biotin-dependent enzyme pyruvate carboxylase by acetyl-CoA. Biochem Soc Trans. 2012;40(3):567–72. https://doi.org/10.1042/bst20120041.
Allick G, van der Crabben SN, Ackermans MT, et al. Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period. Am J Physiol Endocrinol Metab. 2006;290(6):E1212–7. https://doi.org/10.1152/ajpendo.00279.2005.
Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100(18):10158–63. https://doi.org/10.1073/pnas.1733835100.
Bahl JJ, Matsuda M, DeFronzo RA, et al. In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase. Biochem Pharmacol. 1997;53(1):67–74. https://doi.org/10.1016/s0006-2952(96)00660-0.
Bartnik BL, Hovda DA, Lee PW. Glucose metabolism after traumatic brain injury: estimation of pyruvate carboxylase and pyruvate dehydrogenase flux by mass isotopomer analysis. J Neurotrauma. 2007;24(1):181–94. https://doi.org/10.1089/neu.2006.0038.
Beylot M, Soloviev MV, David F, et al. Tracing hepatic gluconeogenesis relative to citric acid cycle activity in vitro and in vivo. Comparisons in the use of [3-13C]lactate, [2-13C]acetate, and alpha-keto[3-13C]isocaproate. J Biol Chem. 1995;270(4):1509–14. https://doi.org/10.1074/jbc.270.4.1509.
Cao Z, Zhou Y, Zhu S, et al. Pyruvate carboxylase activates the RIG-I-like receptor-mediated antiviral immune response by targeting the MAVS signalosome. Sci Rep. 2016;6:22002. https://doi.org/10.1038/srep22002.
Cappel DA, Deja S, Duarte JAG, et al. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab. 2019;29(6):1291–1305.e1298. https://doi.org/10.1016/j.cmet.2019.03.014.
Chen J, Hackett EP, Kovacs Z, et al. Assessment of hepatic pyruvate carboxylase activity using hyperpolarized [1-(13) C]-l-lactate. Magn Reson Med. 2021a;85(3):1175–82. https://doi.org/10.1002/mrm.28489.
Chen J, LaGue E, Li J, et al. Profiling carbohydrate metabolism in liver and hepatocellular carcinoma with [13C]-glycerate probes. Anal Sens. 2021b;1:196–202. https://doi.org/10.1002/anse.202100034.
Cheng T, Sudderth J, Yang C, et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci U S A. 2011;108(21):8674–9. https://doi.org/10.1073/pnas.1016627108.
Cheshkov S, Dimitrov IE, Jakkamsetti V, et al. Oxidation of [U-(13) C]glucose in the human brain at 7T under steady state conditions. Magn Reson Med. 2017;78(6):2065–71. https://doi.org/10.1002/mrm.26603.
Consoli A, Nurjhan N, Reilly JJ Jr, et al. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest. 1990;86(6):2038–45. https://doi.org/10.1172/jci114940.
Haymond MW, Sunehag AL. The reciprocal pool model for the measurement of gluconeogenesis by use of [U-(13)C]glucose. Am J Physiol Endocrinol Metab. 2000;278(1):E140–5. https://doi.org/10.1152/ajpendo.2000.278.1.E140.
Hellerstein MK, Neese RA, Linfoot P, et al. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest. 1997;100(5):1305–19. https://doi.org/10.1172/jci119644.
Jans AW, Kinne RK. 13C NMR spectroscopy as a tool to investigate renal metabolism. Kidney Int. 1991;39(3):430–7. https://doi.org/10.1038/ki.1991.54.
Jenssen T, Nurjhan N, Consoli A, et al. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest. 1990;86(2):489–97. https://doi.org/10.1172/jci114735.
** ES, Moreno KX, Wang JX, et al. Metabolism of hyperpolarized [1-(13)C]pyruvate through alternate pathways in rat liver. NMR Biomed. 2016a;29(4):466–74. https://doi.org/10.1002/nbm.3479.
** ES, Sherry AD, Malloy CR. An oral load of [13C3]glycerol and blood NMR analysis detect fatty acid esterification, pentose phosphate pathway, and glycerol metabolism through the tricarboxylic acid cycle in human liver. J Biol Chem. 2016b;291(36):19031–41. https://doi.org/10.1074/jbc.M116.742262.
Katz J. Determination of gluconeogenesis in vivo with 14C-labeled substrates. Am J Phys. 1985;248(4 Pt 2):R391–9. https://doi.org/10.1152/ajpregu.1985.248.4.R391.
Koenig JB, Dulla CG. Dysregulated glucose metabolism as a therapeutic target to reduce post-traumatic epilepsy. Front Cell Neurosci. 2018;12:350. https://doi.org/10.3389/fncel.2018.00350.
Kumashiro N, Beddow SA, Vatner DF, et al. Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. Diabetes. 2013;62(7):2183–94. https://doi.org/10.2337/db12-1311.
Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, et al. Hyperpolarized (13)C MRI: path to clinical translation in oncology. Neoplasia. 2019;21(1):1–16. https://doi.org/10.1016/j.neo.2018.09.006.
Lee P, Leong W, Tan T, et al. In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model. Hepatology. 2013;57(2):515–24. https://doi.org/10.1002/hep.26028.
Marliss EB, Aoki TT, Unger RH, et al. Glucagon levels and metabolic effects in fasting man. J Clin Invest. 1970;49(12):2256–70. https://doi.org/10.1172/jci106445.
Merritt ME, Harrison C, Sherry AD, et al. Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance. Proc Natl Acad Sci U S A. 2011;108(47):19084–9. https://doi.org/10.1073/pnas.1111247108.
Meyer C, Gerich JE. Role of the human kidney in glucose homeostasis. Curr Opin Endocrinol Diabetes Obes. 2000;7(1):19–24.
Perdigoto R, Rodrigues TB, Furtado AL, et al. Integration of [U-13C]glucose and 2H2O for quantification of hepatic glucose production and gluconeogenesis. NMR Biomed. 2003;16(4):189–98. https://doi.org/10.1002/nbm.826.
Perry RJ, Camporez JG, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–58. https://doi.org/10.1016/j.cell.2015.01.012.
Petersen KF, Befroy DE, Dufour S, et al. Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy. Cell Metab. 2016;24(1):167–71. https://doi.org/10.1016/j.cmet.2016.06.005.
Pilkis SJ, el-Maghrabi MR, Claus TH. Hormonal regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Biochem. 1988;57:755–83. https://doi.org/10.1146/annurev.bi.57.070188.003543.
Rothman DL, Magnusson I, Katz LD, et al. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science. 1991;254(5031):573–6. https://doi.org/10.1126/science.1948033.
Salto R, Sola M, Oliver FJ, et al. Effects of starvation, diabetes and carbon tetrachloride intoxication on rat kidney cortex and liver pyruvate carboxylase levels. Arch Physiol Biochem. 1996;104(7):845–50. https://doi.org/10.1076/apab.104.7.845.13111.
Scrutton MC, White MD. Pyruvate carboxylase. Inhibition of the mammalian and avian liver enzymes by alpha-ketoglutarate and L-glutamate. J Biol Chem. 1974;249(17):5405–15.
Strisower EH, Kohler GD, Chaikoff IL. Incorporation of acetate carbon into glucose by liver slices from normal and alloxan-diabetic rats. J Biol Chem. 1952;198(1):115–26.
Utter MF, Keech DB. Formation of oxaloacetate from pyruvate and carbon dioxide. J Biol Chem. 1960;235:Pc17–8.
Waterhouse C, Keilson J. Cori cycle activity in man. J Clin Invest. 1969;48(12):2359–66. https://doi.org/10.1172/jci106202.
Weber B, Barros LF. The astrocyte: powerhouse and recycling center. Cold Spring Harb Perspect Biol. 2015;7(12):a020396. https://doi.org/10.1101/cshperspect.a020396.
Weinman EO, Strisower EH, Chaikoff IL. Conversion of fatty acids to carbohydrate; application of isotopes to this problem and role of the Krebs cycle as a synthetic pathway. Physiol Rev. 1957;37(2):252–72. https://doi.org/10.1152/physrev.1957.37.2.252.
Wexler ID, Du Y, Lisgaris MV, et al. Primary amino acid sequence and structure of human pyruvate carboxylase. Biochim Biophys Acta. 1994;1227(1–2):46–52. https://doi.org/10.1016/0925-4439(94)90105-8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Chen, J., Park, J.M. (2022). Assessing Pyruvate Carboxylase Flux as a Mechanistic Biological Marker in Fasting. In: Patel, V.B., Preedy, V.R. (eds) Biomarkers in Nutrition . Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Cham. https://doi.org/10.1007/978-3-031-07389-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-031-07389-2_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07388-5
Online ISBN: 978-3-031-07389-2
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences